Literature DB >> 2875664

An unusual cluster of tardive dyskinesia in schizophrenia: association with cognitive dysfunction and negative symptoms.

J L Waddington, H A Youssef.   

Abstract

Factors associated with the emergence or nonemergence of involuntary movements (tardive dyskinesia) during long-term neuroleptic treatment were investigated in an atypical, isolated population of 31 schizophrenic inpatients with an unusually high prevalence of this syndrome. Patients with involuntary movements could not be distinguished from those without such movements by general characteristics or conventional indices of neuroleptic or anticholinergic treatment. However, they were more likely to show either marked cognitive dysfunction or muteness. These findings support the proposal that, at least in schizophrenia, subtle organic changes may contribute to vulnerability to the emergence of involuntary movements.

Entities:  

Mesh:

Substances:

Year:  1986        PMID: 2875664     DOI: 10.1176/ajp.143.9.1162

Source DB:  PubMed          Journal:  Am J Psychiatry        ISSN: 0002-953X            Impact factor:   18.112


  10 in total

1.  Involuntary orofacial movements in hospitalised patients with mental handicap or epilepsy: relationship to developmental/intellectual deficit and presence or absence of long-term exposure to neuroleptics.

Authors:  H A Youssef; J L Waddington
Journal:  J Neurol Neurosurg Psychiatry       Date:  1988-06       Impact factor: 10.154

2.  Chronic neuroleptic effects on spatial reversal learning in monkeys.

Authors:  E D Levin; L M Gunne
Journal:  Psychopharmacology (Berl)       Date:  1989       Impact factor: 4.530

Review 3.  The ageing brain, neuroleptic drugs and the enigma of schizophrenia.

Authors:  J L Waddington
Journal:  Ir J Med Sci       Date:  1988-05       Impact factor: 1.568

4.  Movements in never-medicated schizophrenics: a preliminary study.

Authors:  D S Fenn; D Moussaoui; W F Hoffman; N Kadri; B Bentounssi; A Tilane; M Khomeis; D E Casey
Journal:  Psychopharmacology (Berl)       Date:  1996-01       Impact factor: 4.530

5.  Risk factors for orofacial and limbtruncal tardive dyskinesia in older patients: a prospective longitudinal study.

Authors:  J S Paulsen; M P Caligiuri; B Palmer; L A McAdams; D V Jeste
Journal:  Psychopharmacology (Berl)       Date:  1996-02       Impact factor: 4.530

Review 6.  Drug-induced movement disorders.

Authors:  F J Jiménez-Jiménez; P J García-Ruiz; J A Molina
Journal:  Drug Saf       Date:  1997-03       Impact factor: 5.606

7.  Tardive dystonia. Prevalence, risk factors and clinical features.

Authors:  M Raja; A Azzoni
Journal:  Ital J Neurol Sci       Date:  1996-12

8.  Altered BDNF is correlated to cognition impairment in schizophrenia patients with tardive dyskinesia.

Authors:  Jing Qin Wu; Da Chun Chen; Yun Long Tan; Shu Ping Tan; Li Hui; Men Han Lv; Jair C Soares; Xiang Yang Zhang
Journal:  Psychopharmacology (Berl)       Date:  2014-07-04       Impact factor: 4.530

Review 9.  Negative symptoms, defect state and Huber's basic symptoms: a comparison of the concepts.

Authors:  J de Leon; W H Wilson; G M Simpson
Journal:  Psychiatr Q       Date:  1991

10.  Tardive dystonia. Prevalence, risk factors, and comparison with tardive dyskinesia in a population of 200 acute psychiatric inpatients.

Authors:  M Raja
Journal:  Eur Arch Psychiatry Clin Neurosci       Date:  1995       Impact factor: 5.270

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.